The Receptor for Advanced Glycation Endproducts (RAGE) Contributes to Severe Inflammatory Liver Injury in Mice

The Receptor for Advanced Glycation Endproducts (RAGE) Contributes to Severe Inflammatory Liver Injury in Mice

Background: The receptor for advanced glycation end products (RAGE) is a multiligand receptor involved in a number of processes and disorders. While it is known that RAGE-signaling can contribute to toxic liver damage and fibrosis, its role in acute inflammatory liver injury and septic multiorgan fa...

Full description

Bibliographic Details
Main Authors:	Toni Weinhage, Timo Wirth, Paula Schütz, Philipp Becker, Aloys Lueken, Boris V. Skryabin, Helmut Wittkowski, Dirk Foell
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-06-01
Series:	Frontiers in Immunology
Subjects:	RAGE sepsis inflammatory liver injury PAMPs DAMPs
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2020.01157/full

Similar Items

Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE)
by: Lindsey R. Drake, et al.
Published: (2020-10-01)

Pseudomonas aeruginosa significantly increases expression of receptor for advanced glycation endproducts (RAGE) in the septicemia suffering patients
by: A. Kariminik, et al.
Published: (2021-11-01)

Redox Signaling and Advanced Glycation Endproducts (AGEs) in Diet-Related Diseases
by: Vanesa Cepas, et al.
Published: (2020-02-01)

The receptor for advanced glycation endproducts (RAGE) does not contribute to pathology in a mouse mesenteric ischemia/reperfusion-induced injury model
by: Mike C.L. Wu, et al.
Published: (2015-12-01)

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
by: Lara Caldiroli, et al.
Published: (2022-06-01)

PAMPs and DAMPs in Sepsis: A Review of Their Molecular Features and Potential Clinical Implications
by: Sara Cicchinelli, et al.
Published: (2024-01-01)

Polymorphisms −374 T/A and −429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome
by: Diana Elizabeth González-Guerrero, et al.
Published: (2023-04-01)

Galectin‐3 and RAGE differentially control advanced glycation endproduct‐induced collagen damage in murine intervertebral disc organ culture
by: Zachary S. Gallate, et al.
Published: (2023-06-01)

Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease
by: Kensei Taguchi, et al.
Published: (2021-05-01)

Advanced glycation endproducts mediate chronic kidney injury with characteristic patterns in different stages
by: Xiaoxia Huang, et al.
Published: (2022-09-01)

Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis
by: Rui Wu, et al.
Published: (2020-10-01)

A Potential Role for the Receptor for Advanced Glycation End-Products (RAGE) in the Development of Secondhand Smoke-Induced Chronic Sinusitis
by: Hannah Robin, et al.
Published: (2024-01-01)

RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
by: Lin Brenda, et al.
Published: (2009-03-01)

Antenatal Secondhand Smoke (SHS) Exposure and the Receptor for Advanced Glycation End-Products (RAGE)
by: Katrina L. Curtis, et al.
Published: (2024-01-01)

RAGE Inhibitors in Neurodegenerative Diseases
by: V. Prakash Reddy, et al.
Published: (2023-04-01)

Capsaicin, an active ingredient from chilli peppers, attenuates glycative stress and restores sRAGE levels in diabetic rats
by: Shih-Min Hsia, et al.
Published: (2016-03-01)

Study of the mechanism by gentiopicroside protects against skin fibroblast glycation damage via the RAGE pathway
by: Chunyu Chen, et al.
Published: (2024-02-01)

The receptor for advanced glycation endproducts (RAGE) modulates T cell signaling.
by: James C Reed, et al.
Published: (2020-01-01)

Pathophysiology of RAGE in inflammatory diseases
by: Hanbing Dong, et al.
Published: (2022-07-01)

Satellite Cell Expression of RAGE (Receptor for Advanced Glycation end Products) Is Important for Collateral Vessel Formation
by: Laura Hansen, et al.
Published: (2021-11-01)

Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression
by: Ali H. El-Far, et al.
Published: (2020-05-01)

Inhibition of RAGE Attenuates Cigarette Smoke-Induced Lung Epithelial Cell Damage via RAGE-Mediated Nrf2/DAMP Signaling
by: Hanbyeol Lee, et al.
Published: (2018-07-01)

Complement and coagulation cascades in trauma
by: Abhigyan Satyam, et al.
Published: (2019-10-01)

Advanced glycation end products (AGEs) and their receptor (RAGE) induce apoptosis of periodontal ligament fibroblasts
by: D.X. Li, et al.
Published: (2014-12-01)

Association of the receptor for advanced glycation end-products (RAGE) gene polymorphisms in Malaysian patients with chronic kidney disease
by: Foo Nian Wong, et al.
Published: (2016-04-01)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COVID-19 disease severity and indicator of the need for mechanical ventilation, ARDS and mortality
by: Adeline Lim, et al.
Published: (2021-03-01)

Efek Kortikosteroid Dosis Rendah terhadap Kadar Soluble Receptor for Advanced Glycation End Products Mencit Balb/C Model Sepsis
by: Diding Heri Prasetyo, et al.
Published: (2015-03-01)

Soluble Receptor for Advanced Glycation End Products (sRAGE) is Up-Regulated in Multiple Sclerosis Patients Treated with Interferon β-1a
by: Mahnoosh Rahimi, et al.
Published: (2018-03-01)

Soluble Receptor for Advanced Glycation End Products (sRAGE) Level and Its Prognostic Significance in Children with Acute Lymphoblastic Leukemia
by: Busra Ozkan, et al.
Published: (2024-01-01)

Involvement of RAGE and Oxidative Stress in Inflammatory and Infectious Skin Diseases
by: Fabrizio Guarneri, et al.
Published: (2021-01-01)

RAGE receptor and its soluble isoforms in diabetes mellitus complications
by: Mauren Isfer Anghebem Oliveira, et al.
Published: (2013-04-01)

Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
by: Huan Yang, et al.
Published: (2019-04-01)

Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
by: Sakshi Taneja, et al.
Published: (2021-07-01)

Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases
by: Hidenori Koyama, et al.
Published: (2007-01-01)

Decreased Expression of Pulmonary Homeobox NKX2.1 and Surfactant Protein C in Developing Lungs That Over-Express Receptors for Advanced Glycation End-Products (RAGE)
by: Derek M. Clarke, et al.
Published: (2023-07-01)

Bacterial subversion of NLR-mediated immune responses
by: Ioannis Kienes, et al.
Published: (2022-07-01)

Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants
by: E.N. Miyaji, et al.
Published: (2011-06-01)

Toll-like receptor 4 in inflammation and angiogenesis: a double-edged sword
by: Sheeba eMurad
Published: (2014-07-01)

DAMP signaling in fungal infections and diseases
by: Cristina eCunha, et al.
Published: (2012-09-01)

Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases
by: Christin Pilzweger, et al.
Published: (2015-06-01)